Clinical Trial Update: Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports safety and efficacy results for YPEG-rhG-CSF in cancer patients receiving chemotherapy. The study includes patients with non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• YPEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Non Small Cell Lung Cancer, Breast Cancer | Phase 2 | Status: COMPLETED